Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$1,163,162.00
Apr 1, 2013
Age of Blood in Children in Pediatric Intensive Care Units (ABC-PICU): a multicenter international pragmatic double blind randomized clinical trial on the efficacy of "short storage" red blood cell units to decrease the incidence of new or progressive multiple organ dysfunction syndrome (MODS) in critically ill children
$1,114,530.00
Apr 1, 2013
Persistent Postconcussive Symptoms in Children: A Clinical Prediction Rule Derivation Study
$1,615,914.00
Apr 1, 2013
Clinical, Pathological, Genetic and Biomarker Studies of Frontotemporal Dementia
$1,999,330.00
Apr 1, 2013
Integration of clinical, biomarker, and genetic data for prediction of adverse outcomes in diabetes.
$3,600,000.00
Apr 1, 2013
Clinical Implementation and Outcomes Evaluation of Blood-based Biomarkers for COPD Management
$119,110.00
Apr 1, 2013
Identifying demographic, epidemiologic, clinical outcome and health care utilization trends in Canadians with chronic hepatitis C viral infections over the past two decades.
$1,955,070.00
Apr 1, 2013
IUCPQ application for Core Clinical Center for CTSN network
$249,683.00
Apr 1, 2013
Measuring and modeling tumour evolution from next generation sequencing data: enabling clinical study of clonal diversity in cancer patients
$301,135.00
Mar 21, 2013
New CA over $25,000.
$99,920.00
Mar 1, 2013
Refinement of a clinical decision rule for comprehensive assessment and early detection of patients at risk of persistent symptoms following a mild traumatic brain injury